InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.430
-0.010 (-0.41%)
Jul 30, 2025, 4:00 PM - Market closed
InspireMD Stock Forecast
Stock Price Forecast
The 2 analysts that cover InspireMD stock have a consensus rating of "Strong Buy" and an average price target of $4.5, which forecasts a 85.19% increase in the stock price over the next year. The lowest target is $4 and the highest is $5.
Price Target: $4.5 (+85.19%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for InspireMD stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $4.5 → $4 | Buy | Maintains | $4.5 → $4 | +64.61% | May 12, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +105.76% | Dec 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $4.5 | Buy | Reiterates | $4.5 | +85.19% | Sep 17, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $3.5 → $4.5 | Buy | Maintains | $3.5 → $4.5 | +85.19% | Nov 2, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $3 | Buy | Initiates | $3 | +23.46% | Jun 12, 2023 |
Financial Forecast
Revenue This Year
7.35M
from 7.01M
Increased by 4.85%
Revenue Next Year
15.69M
from 7.35M
Increased by 113.47%
EPS This Year
-1.03
from -0.76
EPS Next Year
-0.93
from -1.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 8.4M | 17.2M | 42.1M |
| Avg | 7.3M | 15.7M | 40.9M |
| Low | 6.3M | 14.1M | 39.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 20.0% | 133.7% | 168.3% |
| Avg | 4.9% | 113.5% | 160.7% |
| Low | -10.5% | 92.0% | 150.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.95 | -0.60 | -0.44 |
| Avg | -1.03 | -0.93 | -0.43 |
| Low | -1.09 | -1.23 | -0.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.